These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22009219)

  • 1. Multicenter randomized clinical trial of retinal photocoagulation for preproliferative diabetic retinopathy.
    ; Sato Y; Kojimahara N; Kitano S; Kato S; Ando N; Yamaguchi N; Hori S
    Jpn J Ophthalmol; 2012 Jan; 56(1):52-9. PubMed ID: 22009219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.
    Nikkhah H; Ghazi H; Razzaghi MR; Karimi S; Ramezani A; Soheilian M
    Int Ophthalmol; 2018 Feb; 38(1):313-321. PubMed ID: 28168567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Observation on clinical effects of panretinal coagulation for diabetic retinopathy].
    Qian Z; Zhu L; Zhao C
    Yan Ke Xue Bao; 2002 Jun; 18(2):99-101. PubMed ID: 15510646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study.
    Muqit MM; Marcellino GR; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE
    Arch Ophthalmol; 2010 May; 128(5):525-33. PubMed ID: 20457972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
    Wilczyński M; Dzivgielewski K
    Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term visual outcome in proliferative diabetic retinopathy patients after panretinal photocoagulation.
    Dogru M; Nakamura M; Inoue M; Yamamoto M
    Jpn J Ophthalmol; 1999; 43(3):217-24. PubMed ID: 10413257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    Gross JG; Glassman AR; Liu D; Sun JK; Antoszyk AN; Baker CW; Bressler NM; Elman MJ; Ferris FL; Gardner TW; Jampol LM; Martin DF; Melia M; Stockdale CR; Beck RW;
    JAMA Ophthalmol; 2018 Oct; 136(10):1138-1148. PubMed ID: 30043039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal Nonperfusion in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation Assessed by Widefield OCT Angiography.
    Russell JF; Al-Khersan H; Shi Y; Scott NL; Hinkle JW; Fan KC; Lyu C; Feuer WJ; Gregori G; Rosenfeld PJ
    Am J Ophthalmol; 2020 May; 213():177-185. PubMed ID: 32006481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study.
    Muqit MM; Young LB; McKenzie R; John B; Marcellino GR; Henson DB; Turner GS; Stanga PE
    Br J Ophthalmol; 2013 Feb; 97(2):220-7. PubMed ID: 23178855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral capillary non-perfusion in treatment-naïve proliferative diabetic retinopathy associates with postoperative disease activity 6 months after panretinal photocoagulation.
    Torp TL; Kawasaki R; Wong TY; Peto T; Grauslund J
    Br J Ophthalmol; 2019 Jun; 103(6):816-820. PubMed ID: 30068515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic Nephropathy in Type 2 Diabetic Retinopathy Requiring Panretinal Photocoagulation.
    Ha M; Choi SY; Kim M; Na JK; Park YH
    Korean J Ophthalmol; 2019 Feb; 33(1):46-53. PubMed ID: 30746911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
    Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
    Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
    Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of navigated panretinal photocoagulation in proliferative diabetic retinopathy.
    Chhablani J; Sambhana S; Mathai A; Gupta V; Arevalo JF; Kozak I
    Am J Ophthalmol; 2015 May; 159(5):884-9. PubMed ID: 25703478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
    Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.
    Hutton DW; Stein JD; Bressler NM; Jampol LM; Browning D; Glassman AR;
    JAMA Ophthalmol; 2017 Jun; 135(6):576-584. PubMed ID: 28492920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central retinal thickness following panretinal photocoagulation using a multispot semi-automated pattern-scanning laser to treat ischaemic diabetic retinopathy: Treatment in one session compared with four monthly sessions.
    Gabrielle PH; Massin P; Kodjikian L; Erginay A; Pallot C; Jonval L; Soudry A; Couturier A; Vardanian-Vartin C; Bron AM; Creuzot-Garcher C
    Acta Ophthalmol; 2019 Aug; 97(5):e680-e687. PubMed ID: 30561087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4.
    Muqit MM; Marcellino GR; Henson DB; Young LB; Turner GS; Stanga PE
    Eye (Lond); 2011 Nov; 25(11):1447-56. PubMed ID: 21818132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Comfort with Yellow (577 nm) vs. Green (532 nm) Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy.
    Adam MK; Weinstock BM; Kasi SK; Ehmann DS; Hsu J; Garg SJ; Ho AC; Chiang A
    Ophthalmol Retina; 2018 Feb; 2(2):91-95. PubMed ID: 31047351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reading deficits in diabetic patients treated with panretinal photocoagulation and good visual acuity.
    Omari A; Niziol LM; Gardner TW
    Acta Ophthalmol; 2019 Nov; 97(7):e1013-e1018. PubMed ID: 30968579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.